Baxter ROE 2010-2024 | BAX
Current and historical return on equity (ROE) values for Baxter (BAX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Baxter ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $-0.65B | $7.02B | -8.40% |
| 2024-09-30 | $0.11B | $7.94B | 1.34% |
| 2024-06-30 | $2.48B | $7.71B | 30.40% |
| 2024-03-31 | $2.65B | $8.24B | 34.74% |
| 2023-12-31 | $2.66B | $8.47B | 37.67% |
| 2023-09-30 | $2.59B | $8.17B | 40.45% |
| 2023-06-30 | $-2.85B | $5.63B | -49.52% |
| 2023-03-31 | $-2.46B | $5.94B | -37.39% |
| 2022-12-31 | $-2.43B | $5.90B | -32.99% |
| 2022-09-30 | $-2.38B | $5.58B | -29.04% |
| 2022-06-30 | $1.01B | $8.90B | 11.25% |
| 2022-03-31 | $1.06B | $9.12B | 11.88% |
| 2021-12-31 | $1.28B | $9.12B | 14.69% |
| 2021-09-30 | $1.21B | $8.82B | 14.05% |
| 2021-06-30 | $1.12B | $8.54B | 13.04% |
| 2021-03-31 | $1.07B | $8.49B | 12.57% |
| 2020-12-31 | $1.10B | $8.73B | 13.27% |
| 2020-09-30 | $0.91B | $8.60B | 11.25% |
| 2020-06-30 | $0.92B | $8.16B | 11.76% |
| 2020-03-31 | $0.99B | $7.73B | 12.75% |
| 2019-12-31 | $1.00B | $7.91B | 12.90% |
| 2019-09-30 | $1.32B | $7.62B | 17.04% |
| 2019-06-30 | $1.47B | $7.84B | 18.09% |
| 2019-03-31 | $1.50B | $7.67B | 17.89% |
| 2018-12-31 | $1.55B | $7.87B | 17.70% |
| 2018-09-30 | $1.06B | $9.11B | 11.76% |
| 2018-06-30 | $0.80B | $8.87B | 8.73% |
| 2018-03-31 | $0.72B | $9.09B | 7.81% |
| 2017-12-31 | $0.60B | $9.12B | 6.61% |
| 2017-09-30 | $1.03B | $9.46B | 11.59% |
| 2017-06-30 | $0.91B | $9.17B | 10.46% |
| 2017-03-31 | $1.86B | $8.68B | 21.76% |
| 2016-12-31 | $4.97B | $8.28B | 57.61% |
| 2016-09-30 | $4.93B | $8.66B | 56.21% |
| 2016-06-30 | $4.80B | $8.51B | 56.05% |
| 2016-03-31 | $3.92B | $9.02B | 46.43% |
| 2015-12-31 | $0.97B | $8.87B | 12.09% |
| 2015-09-30 | $1.72B | $7.85B | 21.92% |
| 2015-06-30 | $2.18B | $8.02B | 27.38% |
| 2015-03-31 | $2.37B | $7.29B | 29.13% |
| 2014-12-31 | $2.50B | $8.16B | 29.41% |
| 2014-09-30 | $1.87B | $8.43B | 21.81% |
| 2014-06-30 | $1.95B | $8.69B | 23.16% |
| 2014-03-31 | $2.02B | $8.69B | 25.01% |
| 2013-12-31 | $2.01B | $8.49B | 26.35% |
| 2013-09-30 | $2.18B | $7.75B | 30.03% |
| 2013-06-30 | $2.22B | $7.32B | 31.16% |
| 2013-03-31 | $2.29B | $7.00B | 32.97% |
| 2012-12-31 | $2.33B | $6.98B | 33.54% |
| 2012-09-30 | $2.30B | $7.19B | 33.27% |
| 2012-06-30 | $2.29B | $6.61B | 33.17% |
| 2012-03-31 | $2.24B | $6.96B | 31.77% |
| 2011-12-31 | $2.22B | $6.83B | 31.51% |
| 2011-09-30 | $2.18B | $7.19B | 30.98% |
| 2011-06-30 | $2.13B | $7.24B | 30.72% |
| 2011-03-31 | $2.05B | $6.97B | 30.80% |
| 2010-12-31 | $1.42B | $6.80B | 21.55% |
| 2010-09-30 | $1.57B | $6.76B | 23.27% |
| 2010-06-30 | $1.57B | $6.13B | 22.87% |
| 2010-03-31 | $1.63B | $6.66B | 23.09% |
| 2009-12-31 | $2.21B | $7.42B | 31.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.890B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.329B | 27.30 |
| Boston Scientific (BSX) | United States | $151.960B | 38.05 |
| Stryker (SYK) | United States | $141.576B | 30.43 |
| EssilorLuxottica (ESLOY) | France | $131.433B | 0.00 |
| Medtronic (MDT) | Ireland | $108.503B | 15.84 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.360B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.382B | 26.36 |
| ResMed (RMD) | United States | $34.859B | 26.18 |
| GE HealthCare Technologies (GEHC) | United States | $31.175B | 15.16 |
| Agilent Technologies (A) | United States | $30.637B | 20.24 |
| Terumo (TRUMY) | Japan | $28.678B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.336B | 12.85 |
| Insulet (PODD) | United States | $17.646B | 75.46 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.790B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Demant (WILYY) | Denmark | $7.600B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.119B | 17.50 |
| Bio-Rad Laboratories (BIO) | United States | $6.788B | 23.50 |
| Prestige Consumer Healthcare (PBH) | United States | $4.059B | 19.37 |
| Perrigo (PRGO) | Ireland | $3.496B | 10.01 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.378B | 28.78 |
| Haemonetics (HAE) | United States | $3.214B | 15.12 |
| Envista Holdings (NVST) | United States | $2.745B | 22.19 |
| GN Store Nord (GNNDY) | Denmark | $2.260B | 15.23 |
| LeMaitre Vascular (LMAT) | United States | $2.092B | 47.73 |
| QuidelOrtho (QDEL) | United States | $1.928B | 16.15 |
| AtriCure (ATRC) | United States | $1.715B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.258B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.250B | 19.63 |
| BioLife Solutions (BLFS) | United States | $1.174B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.129B | 10.87 |
| Neogen (NEOG) | United States | $1.092B | 13.97 |
| InMode (INMD) | Israel | $1.003B | 9.18 |
| Phibro Animal Health (PAHC) | United States | $0.765B | 11.73 |
| Evolus (EOLS) | United States | $0.746B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.596B | 0.00 |
| CeriBell (CBLL) | United States | $0.587B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.574B | 0.00 |
| Owens & Minor (OMI) | United States | $0.541B | 4.61 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.493B | 0.00 |
| Surmodics (SRDX) | United States | $0.442B | 0.00 |
| Omeros (OMER) | United States | $0.419B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.414B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.357B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.346B | 15.02 |
| Verano Holdings (VRNOF) | United States | $0.307B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 24.82 |
| ZimVie (ZIMV) | United States | $0.264B | 15.78 |
| Aurora Cannabis (ACB) | Canada | $0.261B | 46.40 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.237B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.220B | 0.00 |
| High Tide (HITI) | Canada | $0.196B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 4.43 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.89 |
| Brainsway (BWAY) | Israel | $0.168B | 52.29 |
| Organigram Global (OGI) | Canada | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 17.99 |
| Jin Medical (ZJYL) | China | $0.140B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| Agape ATP (ATPC) | $0.121B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.108B | 0.00 |
| MacroGenics (MGNX) | United States | $0.101B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Fonar (FONR) | United States | $0.078B | 10.86 |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.068B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 0.00 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 55.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 11.11 |
| Apyx Medical (APYX) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |